Inhibitor Therapeutics sues investor for failing to close $3M financing

Inhibitor Therapeutics, Inc.

Filed suit March 30, 2026 against an institutional investor for breach of the Securities Purchase Agreement.
Investor failed to fund $3,000,000 investment for 12,000,000 shares and 7,000,000 warrants at $0.25 per share.
Company attempted to secure funds without litigation before initiating the suit.
Additional details on the litigation to be provided in a subsequent Form 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.